Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Edward Fon × Clear Filters

8 results found

The Canadian Optogenetics and Vectorology Foundry

Optogenetics, defined as a technique where light-sensitive genes are introduced into brain cells to control their activity with light, allows researchers to precisely control nerve cell communication thereby, transforming brain research.

Project ongoing See Project & Researchers
Grant type
Platform grants
Area of Research
Central Nervous System
Competition
2024 Platform Support Grants
Province
Québec
Start Date
2025

Canadian Optogenetics and Vectorology Foundry

Optogenetics is a relatively new science subdomain that is revolutionizing brain research with great promises for therapeutics.

Project ongoing See Project & Researchers
Grant type
Platform grants
Area of Research
Neurotechnology
Competition
2019 Platform Support Grants
Province
Québec
Start Date
2020

Development of a high throughput 3D microphysiologicalplatform for rapid automated assessment of human brain organoids response to drugs targeting neurological disorders

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common and devastating neurological diseases, with over 750,000 AD patients and over 100,000 PD patients in Canada.

Project completed See Project & Researchers
Grant type
Platform grants
Area of Research
Neurodegeneration
Competition
CQDM - Brain Canada - Quantum Leap
Province
Québec
Start Date
2020

Canadian Open Parkinson Network (C-OPN)

The Canadian Open Parkinson Network, or C-OPN, is a national network that unites researchers, physicians and patients across Canada to study Parkinson’s disease (PD).

Project ongoing See Project & Researchers
Grant type
Platform grants
Area of Research
Neurodegeneration
Competition
Other
Province
Alberta
Start Date
2018

A patient-derived iPSC platform of disease relevant cell models for biological studies

One of the greatest advancements in science over the past 10 years is the development of induced pluripotent stem cells (iPSCs).

Project ongoing See Project & Researchers
Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Arthur J. Hudson Translational Team Grant
Province
Québec
Start Date
2017

A Patient-Derived hiPSC Neuronal Platform for Drug Discovery in Parkinson’s Disease and Amyotrophic Lateral Sclerosis

Parkinson’s Disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are two of the most common and devastating neurodegenerative diseases, affecting more than 2% of the population over the age of 65.

Project completed See Project & Researchers
Grant type
Platform grants
Area of Research
Neurodegeneration
Competition
CQDM - Brain Canada - Focus on Brain
Province
Québec
Start Date
2016

Human inducible pluripotent stem cells (iPSC) platform

Studies of genetic disorders are limited because of the lack of appropriate tissue samples from patients.

Project completed See Project & Researchers
Grant type
Platform grants
Area of Research
Neurotechnology
Competition
2014 Platform Grants
Province
Québec
Start Date
2015

Mitochondrial dysfunction and neuronal demise: Insights provided by Parkinson’s disease genes

Converging research efforts have recently identified five genes that are associated with familial Parkinson’s Disease (PD), a condition associated with severe motor dysfunction and loss of dopamine-producing cells in the brain.

Project completed See Project & Researchers
Grant type
Team grants
Competition
Brain Repair Program
Province
Québec
Start Date
2007